Level Four Advisory Services, LLC Gilead Sciences, Inc. Transaction History
Level Four Advisory Services, LLC
- $2.11 Billion
- Q2 2024
A detailed history of Level Four Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 32,314 shares of GILD stock, worth $2.85 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
32,314
Previous 3,313
875.37%
Holding current value
$2.85 Million
Previous $242,000
816.12%
% of portfolio
0.11%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
1,893Shares Held
1.02BCall Options Held
12MPut Options Held
9.04M-
Black Rock Inc. New York, NY121MShares$10.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.72 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.32 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.23 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...